Retraction in Part: A Genomic Approach to Identify Molecular Pathways Associated with Chemotherapy Resistance | Citedby Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Retraction in Part: A Genomic Approach to Identify Molecular Pathways Associated with Chemotherapy Resistance

Mol Cancer Ther (2012) 11 (5): 1214–1215.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Luteolin-loading of Her-2-poly (lactic-co-glycolic acid) nanoparticles and proliferative inhibition of gastric cancer cells via targeted regulation of forkhead box protein O1

Jian Ding
Qiu Li
ShanShan He
Jie Xie
XiaoFei Liang
Ting Wu
Dan Li

Journal of Cancer Research and Therapeutics (2020) 16 (2): 263.

Systems biology approaches for advancing the discovery of effective drug combinations

Karen A Ryall
Aik Choon Tan

Journal of Cheminformatics (2015) 7 (1)